2026-2030年全球微陣列分析市場

全球微陣列分析市場預計將從 2025 年到 2030 年成長至 16.786 億美元，預測期內複合年成長率為 5.6%。

這份關於全球微陣列分析市場的報告提供了全面的分析，包括市場規模和預測、趨勢、成長要素、挑戰以及涵蓋約 25 家供應商的供應商分析。

本報告對當前市場狀況、最新趨勢和促進因素以及整體市場環境進行了最新分析。推動該市場發展的因素包括慢性病盛行率上升、精準醫療模式的擴展以及基因組研究經費的增加。

本研究客觀地結合了一手和二手訊息，包括來自主要行業相關人員的信息。報告內容涵蓋主要公司分析、全面的市場規模數據、區域細分分析以及供應商格局。報告包含歷史數據和預測數據。

本研究指出，基因體學研究經費的增加是未來幾年全球微陣列分析市場成長的主要驅動力之一。此外，藥物研發領域應用範圍的擴大以及與先進生物資訊技術的融合，預計也將帶來顯著的市場需求。

目錄

第1章：執行摘要

第2章 Technavio 分析

• 分析定價、生命週期、顧客購買籃子、採用率和購買標準。
• 輸入的重要性及差異化因素
• 干擾因素
• 促進因素和挑戰的影響

第3章 市場狀況

• 市場生態系統
• 市場特徵
• 價值鏈分析

第4章 市場規模

• 市場的定義
• 市場區隔分析
• 2025年市場規模
• 市場展望，2025-2030年

第5章 市場規模與表現

• 2020-2024年全球微陣列分析市場
• 2020-2024年服務型市場區隔分析
• 基於應用領域的細分市場分析，2020-2024 年
• 2020年至2024年最終用戶細分市場分析
• 區域區隔市場分析，2020-2024 年
• 2020-2024年各國細分市場分析

第6章 定性分析

• 人工智慧的影響：全球微陣列分析市場
• 地緣政治衝突的影響：全球微陣列分析市場

第7章：五力分析

第8章 市場區隔：依服務

• 比較：按服務
• 消耗品
• 裝置
• 軟體服務
• 市場機會：依服務分類

第9章 市場區隔：依應用

• 比較：按應用
• 出於研究目的
• 藥物發現
• 疾病診斷
• 其他
• 市場機會：依應用領域分類

第10章 市場區隔：依最終用戶分類

• 比較：按最終用戶
• 研究和學術機構
• 製藥和生物技術公司
• 診斷檢查室
• 市場機會：依最終用戶分類

第11章 客戶情況

第12章 區域情勢

• 區域細分
• 區域比較
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 荷蘭
• 亞洲
  • 中國
  • 印度
  • 日本
  • 韓國
  • 印尼
  • 泰國
• 世界其他地區（RoW）
  • 巴西
  • 沙烏地阿拉伯
  • UAE
  • 土耳其
  • 阿根廷
  • 哥倫比亞
  • 南非
  • 以色列
• 市場機會：按地區分類

第13章 促進因素、挑戰與機遇

• 市場促進因素
• 市場挑戰
• 促進因素和挑戰的影響
• 市場機遇

第14章 競爭格局

• 概述
• 競爭格局
• 混亂局面
• 產業風險

第15章 競爭分析

• 公司簡介
• 公司排名指標
• 企業市場定位
• Agilent Technologies Inc.
• Akonni Biosystems Inc.
• Bio Techne Corp.
• CapitalBio Technology Co. Ltd.
• EpiGentek Group Inc.
• Grace Bio Labs
• Illumina Inc.
• Innopsys Inc.
• JPT Peptide Technologies GmbH
• Molecular Device LLC
• OriGene Technologies Inc.
• Oxford Gene Technology Group
• SCHOTT AG
• Scienion AG
• Thermo Fisher Scientific Inc.

第16章附錄

The global microarray analysis market is forecasted to grow by USD 1678.6 mn during 2025-2030, accelerating at a CAGR of 5.6% during the forecast period. The report on the global microarray analysis market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of chronic diseases, expansion of precision medicine paradigms, rise in genomic research funding.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global microarray analysis market is segmented as below:

By Service

• Consumables
• Instruments
• Software and services

By Application

• Research applications
• Drug discovery
• Disease diagnostics
• Others

By End-User

• Research and academic institutes
• Pharmaceutical and biotechnology companies
• Diagnostic laboratories

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the expansion of genomic research funding as one of the prime reasons driving the global microarray analysis market growth during the next few years. Also, growth in drug discovery applications and integration with advanced bioinformatics will lead to sizable demand in the market.

The report on the global microarray analysis market covers the following areas:

• Global microarray analysis market sizing
• Global microarray analysis market forecast
• Global microarray analysis market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global microarray analysis market vendors that include Agilent Technologies Inc., Akonni Biosystems Inc., Bio Techne Corp., CapitalBio Technology Co. Ltd., EpiGentek Group Inc., Full Moon BioSystems Inc., Grace Bio Labs, Illumina Inc., Innopsys Inc., JPT Peptide Technologies GmbH, Molecular Device LLC, OriGene Technologies Inc., Oxford Gene Technology Group, PathogenDx Inc., RayBiotech Life Inc., SCHOTT AG, Scienion AG, Signosis Inc., SomaLogic Inc., Thermo Fisher Scientific Inc.. Also, the global microarray analysis market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Service
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Microarray Analysis Market 2020 - 2024
  • Historic Market Size - Data Table on Global Microarray Analysis Market 2020 - 2024 ($ million)
• 5.2 Service segment analysis 2020 - 2024
  • Historic Market Size - Service Segment 2020 - 2024 ($ million)
• 5.3 Application segment analysis 2020 - 2024
  • Historic Market Size - Application Segment 2020 - 2024 ($ million)
• 5.4 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on Global Microarray Analysis Market
• 6.2 Impact of geopolitical conflicts on Global Microarray Analysis Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Service

• 8.1 Market segments
• 8.2 Comparison by Service
• 8.3 Consumables - Market size and forecast 2025-2030
• 8.4 Instruments - Market size and forecast 2025-2030
• 8.5 Software and services - Market size and forecast 2025-2030
• 8.6 Market opportunity by Service
  • Market opportunity by Service ($ million)

9 Market Segmentation by Application

• 9.1 Market segments
• 9.2 Comparison by Application
• 9.3 Research applications - Market size and forecast 2025-2030
• 9.4 Drug discovery - Market size and forecast 2025-2030
• 9.5 Disease diagnostics - Market size and forecast 2025-2030
• 9.6 Others - Market size and forecast 2025-2030
• 9.7 Market opportunity by Application
  • Market opportunity by Application ($ million)

10 Market Segmentation by End-user

• 10.1 Market segments
• 10.2 Comparison by End-user
• 10.3 Research and academic institutes - Market size and forecast 2025-2030
• 10.4 Pharmaceutical and biotechnology companies - Market size and forecast 2025-2030
• 10.5 Diagnostic laboratories - Market size and forecast 2025-2030
• 10.6 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 India - Market size and forecast 2025-2030
  • 12.5.3 Japan - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Indonesia - Market size and forecast 2025-2030
  • 12.5.6 Thailand - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.3 UAE - Market size and forecast 2025-2030
  • 12.6.4 Turkey - Market size and forecast 2025-2030
  • 12.6.5 Argentina - Market size and forecast 2025-2030
  • 12.6.6 Colombia - Market size and forecast 2025-2030
  • 12.6.7 South Africa - Market size and forecast 2025-2030
  • 12.6.8 Israel - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Rising prevalence of chronic diseases
  • Expansion of precision medicine paradigms
  • Rise in genomic research funding
• 13.2 Market challenges
  • Intense competition from sequencing technologies
  • High instrument and consumable costs
  • Stringent regulatory approval processes
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Expansion of genomic research funding
  • Growth in drug discovery applications
  • Integration with advanced bioinformatics

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Agilent Technologies Inc.
  • Agilent Technologies Inc. - Overview
  • Agilent Technologies Inc. - Business segments
  • Agilent Technologies Inc. - Key news
  • Agilent Technologies Inc. - Key offerings
  • Agilent Technologies Inc. - Segment focus
  • SWOT
• 15.5 Akonni Biosystems Inc.
  • Akonni Biosystems Inc. - Overview
  • Akonni Biosystems Inc. - Product / Service
  • Akonni Biosystems Inc. - Key offerings
  • SWOT
• 15.6 Bio Techne Corp.
  • Bio Techne Corp. - Overview
  • Bio Techne Corp. - Business segments
  • Bio Techne Corp. - Key news
  • Bio Techne Corp. - Key offerings
  • Bio Techne Corp. - Segment focus
  • SWOT
• 15.7 CapitalBio Technology Co. Ltd.
  • CapitalBio Technology Co. Ltd. - Overview
  • CapitalBio Technology Co. Ltd. - Product / Service
  • CapitalBio Technology Co. Ltd. - Key offerings
  • SWOT
• 15.8 EpiGentek Group Inc.
  • EpiGentek Group Inc. - Overview
  • EpiGentek Group Inc. - Product / Service
  • EpiGentek Group Inc. - Key offerings
  • SWOT
• 15.9 Grace Bio Labs
  • Grace Bio Labs - Overview
  • Grace Bio Labs - Product / Service
  • Grace Bio Labs - Key offerings
  • SWOT
• 15.10 Illumina Inc.
  • Illumina Inc. - Overview
  • Illumina Inc. - Business segments
  • Illumina Inc. - Key news
  • Illumina Inc. - Key offerings
  • Illumina Inc. - Segment focus
  • SWOT
• 15.11 Innopsys Inc.
  • Innopsys Inc. - Overview
  • Innopsys Inc. - Product / Service
  • Innopsys Inc. - Key offerings
  • SWOT
• 15.12 JPT Peptide Technologies GmbH
  • JPT Peptide Technologies GmbH - Overview
  • JPT Peptide Technologies GmbH - Product / Service
  • JPT Peptide Technologies GmbH - Key offerings
  • SWOT
• 15.13 Molecular Device LLC
  • Molecular Device LLC - Overview
  • Molecular Device LLC - Product / Service
  • Molecular Device LLC - Key offerings
  • SWOT
• 15.14 OriGene Technologies Inc.
  • OriGene Technologies Inc. - Overview
  • OriGene Technologies Inc. - Product / Service
  • OriGene Technologies Inc. - Key offerings
  • SWOT
• 15.15 Oxford Gene Technology Group
  • Oxford Gene Technology Group - Overview
  • Oxford Gene Technology Group - Product / Service
  • Oxford Gene Technology Group - Key offerings
  • SWOT
• 15.16 SCHOTT AG
  • SCHOTT AG - Overview
  • SCHOTT AG - Product / Service
  • SCHOTT AG - Key offerings
  • SWOT
• 15.17 Scienion AG
  • Scienion AG - Overview
  • Scienion AG - Product / Service
  • Scienion AG - Key offerings
  • SWOT
• 15.18 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations